ankushmakde

[ankushmakde]

Miniature Pneumatics Market expected to grow at a CAGR of 4.9% from 2020 to 2027

According to our latest market study on “Miniature Pneumatics Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type (Valves, Cylinder, Manifolds and Tubing, Specialized Components, and Others) and Application (Semiconductor, HVAC Systems, Aerospace, Medical Instrument, Test/Analytics Equipment, Automotive, and Others),” the market was valued at US$ 1,856.0 million in 2019 and is projected to reach US$ 2,725.7 million by 2027; it is expected to grow at a CAGR of 4.9% from 2020 to 2027. The report highlights key factors driving the market growth, and prominent players with their developments in the market.

The performance of pneumatic control systems is based on the equipment and machine's size. Similarly, the pneumadyne manufacturers are designing the miniature pneumatic components that are used to deliver outstanding performance in small packages. The miniature pneumatic valves, solenoids, fittings, and manifolds are designed to be used for light- to medium-duty applications and control the equipment's operation varies from medical and dental equipment to laboratory instrumentation. The miniature pneumatics are compact and lightweight, as well as they are manufactured with high-quality standards. The growing adoption of miniature pneumatics is creating a demand for efficient products and solutions, which is bolstering the growth of the miniature pneumatics market. ASCO, Beswick Engineering, Clippard, Industrial Specialties MFG, Kendrion, and Norgren Limited are among the key market players that were profiled during this market study.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00017508/

 Impact of COVID–19 Pandemic on Miniature Pneumatics Market

The emergence and rapid spread of novel coronavirus has paralyzed numerous countries. The COVID-19 pandemic has shaken several industries. The tremendous growth in the spread of the virus has urged governments worldwide to impose strict restrictions on vehicles and human’s movement. Due to travel bans, mass lockdowns, and business shutdowns, the pandemic is adversely affecting economies and countless industries in various countries. The lockdown imposition has resulted in lesser production of commodities, goods, and services. Manufacturing, automotive, semiconductor & electronics, oil & gas, mining, aviation, and other industries are witnessing a decline in their operations due to the temporary shutdown of activities. The miniature pneumatics market players are also experiencing a slowdown in the volumes because the manufacturing facilities are operating with a limited workforce, which is hindering the market. Additionally, temporary closure of various factories has resulted in reduced procurement of systems among industries during the first quarter of 2020. The COVID-19 outbreak might have its impact in the first six months of 2021 as well.

The global miniature pneumatics market has been segmented as follows:

Miniature Pneumatics Market – by Types

Valves

Cylinder

Manifolds and Tubing

Specialized Components

Others

Miniature Pneumatics Market – by Application

Semiconductor

HVAC Systems

Aerospace

Medical Instrument

Test/Analytics Equipment

Automotive

Others

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Organoids Market 2022 Global Trends, Share, Growth, Analysis, Opportunities and Forecast to 2027

According to a new market research study titled “Organoids Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type, Application, and Source,” the global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. The report highlights the trends prevalent in the global organoids market and the factors driving the market along with those that act as deterrents to its growth. The market is expected to grow due to increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing models.

Animal models are widely used in biomedical research for human-specific diseases. However, various cases demonstrate that animal models cannot always be predictive for human drug response, for instance, drug toxicology studies. This is because there are wide variations in the metabolism of drugs and toxins in humans compared to animals, which makes it nearly impossible to study drug metabolism in experimental models, such as laboratory rodent species. Additionally, in recent years, several regulations have been implemented that restrict animal use in research activities. Similarly, several bodies, such as Cruelty-Free International and the Fund for the Replacement of Animals in Medical Experiments, oppose animal-based models for research purposes.

Therefore, in order to develop alternative testing models that can provide an environment with full equivalence to the human body, various institutes are involved in developing alternative methods for drug development and biomedical research. As organoids can serve as alternatives to animal models, the current focus on reducing animal use in research is expected to support the growth of the human organoids market.

Download Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00017616/

Based on type, the global organoids market is segmented into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. In 2019, the intestine segment held the largest market share. This segment is also expected to dominate the market in 2027 as various experimental techniques have also been developed in parallel with, and applied to, intestinal organoid cultures with a scientifically synergistic effect. Moreover, the kidney segment is anticipated to grow at the fastest rate during the forecast period.

The emergence of coronavirus pandemic is estimated to have a significant impact on the organoids market. Majority of the pharmaceutical companies around the globe are engaged in the development of vaccine for coronavirus. Moreover, COVID-19 has also caused increased interest in human lung organoid models.  However, this shift of focus is anticipated to have a positive impact on the other segments of the market. Disruptions in supply chain caused due to halt in global operations are projected to have an adverse impact on the market.

Prominent players operating in organoids market include STEMCELL Technologies, Inc.; Cellesce Ltd.; Hubrecht Organoid Technology; Definigen, 3Dnamics, Inc.; Organoid Therapeutics; PeproTech, Inc.; Thermo Fisher Scientific; Corning Incorporated (Life Sciences); and Merck KGgA.

The market players are focused toward bringing new and innovative products and services to sustain their position in the market. For instance, in January 2020 Merck and BioMed X0020collaborated a for new research program in autoimmune diseases. This research would involve use of conventional and high-throughput metagenomics and generation of intestinal organoids from murine and human subjects for identification of biomarkers of autoimmune diseases. Such developments are expected to boost the market growth during the forecast period.

The report segments the global organoids market as follows:

Global Organoids Market – by Type

Stomach

Intestine

Liver

Pancreas

Lung

Brain

Kidney

Others

Global Organoids Market – by Application

Developmental Biology

Disease Pathology of Infectious Disease

Regenerative Medicine

Drug Toxicity and Efficacy Testing

Drug Discovery and Personalized Medicine

Others

Global Organoids Market – by Source

Pluripotent Stem Cells

Organ-Specific Adult Stem Cells

Merck KGaA and Thermo Fisher Scientific Inc. - Notable Market Participants in Transient Protein Expression Industry

The transient protein expression market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the transient protein expression market are present globally and have wide distribution and sales network through partnerships or authorized dealers.

The most notable market participants are Thermo Fisher Scientific, Promega Corporation, Merck Kgaa, Takara Bio Inc, Qiagen, Genscript, Meridian Bioscience, Inc, Agilent Technologies, Inc., New England Biolabs, And Mirus Bio Llc., Sino Biological Inc. occupying a considerable share of the market owing to their offerings to the market.

Market leaders are involved in extensive research for the development of new transient protein expression and therapeutics with better efficiency and treatment outcomes. For instance, in Jan 2020, Ambrx and Sino Biopharma Announced Collaboration to Develop Two Next-Generation Biologics to develop two products enabled by Ambrx's unique non-natural amino acid incorporation technology platforms. The collaboration combines Ambrx's clinically validated ReCODE and EuCODE platforms with Sino Biopharma's strong resources and commitment to bring next-generation biologic drugs to market.

Many well-known as well as small local companies are present in the market to provide diversified products to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally various companies are also undergoing other strategic alliances such as collaborations and others to garner their significance and remain competitive in the market.

Few on the important key developments from the industry are mentioned below:

2020    Merck signed agreements licensing its CRISPR technology to two companies PanCELLa, a cell therapy firm, and Takara Bio USA, Inc., a biotechnology company. Licenses aim to accelerate drug discovery research leading to the development of new therapies, PanCELLa agreement marks Merck’s first CRISPR license for bioproduction, Takara Bio USA agreement gives access to Merck’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services.         

2018    QIAGEN announced the appointment of The Scientific Group, a South Africa-based company and a wholly-owned subsidiary of Ascendis Medical, as its exclusive commercial partner for Africa, excluding South Africa and the Maghreb. The agreement will raise the profile of QIAGEN’s Sample to Insight solutions in Africa and benefit a region with growing needs for modern molecular testing technologies in healthcare and the life sciences.        

2017    Thermo Fisher Scientific Inc. launched its new PureLink Fast Low-Endotoxin Plasmid Purification Midi and Maxi Kits which significantly reduces plasmid purification time to accelerate protein expression         North America

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com Phone: +1–646–491–9876

[ankushmakde]

IR Spectroscopy Market is expected to reach US$ 1,998.22 million by 2028, registering a CAGR of 6.3% from 2021 to 2028.

According to the new research report titled “IR Spectroscopy Market Forecast to 2028 – COVID-19 Impact and Global Analysis,” published by The Insight Partners, the market is expected to reach US$ 1,998.22 million by 2028, registering a CAGR of 6.3% from 2021 to 2028.

Spectroscopy is paving the path of sampling for testing purpose in varied applications, including healthcare and medical research. In mentioned applications, spectroscopy is used as a tool for enhancing diagnostics, sensing, and disease detection. In the past few years, many advancements have evolved spectroscopes from near-IR to UV-VIS for biomedical and several other applications. Factors such as growing number of medical facilities and clinical research centers across the world to better serve the needs of patients and medical staff and increasing investments in healthcare & pharmaceutical industries to encourage R&D in mentioned industries are contributing toward the market growth. Also, the Asian market houses varied industries—ranging from manufacturing to oil & gas—which is further raising the demand for IR spectroscopes for testing and sampling purposes. Moreover, the emergence of lightweight and compact portable/handheld spectroscopes to assist in on-field applications is another factor anticipated to bring growth prospects for the manufacturers and providers of IR spectroscopy. Also, rising number of food processing units and increasing dairy operations across the world are creating significant opportunities for the IR spectroscopy manufacturers, which, in turn, is expected to propel the growth of the IR spectroscopy market during the forecast period.

Request for Sample report @ https://www.theinsightpartners.com/sample/TIPRE00017506/

Key Findings of Study:

Geographically, the IR spectroscopy market is broadly segmented into five major regions—North America, Europe, APAC, MEA, and SAM. The infrared spectroscopy is an analytical technique receiving high momentum among laboratories at a global scale owing to its versatility and simplicity. This technique gives rapid quantitative & qualitative information with minimal sample preparation.

In 2020, North America held the largest revenue share of global IR spectroscopy market. The region attracts numerous technological developments in the field of IR spectroscopy which is driving the market in North America. For instance, Agilent Technologies, Inc. released MassHunter Workstation Plus 11.0, MassHunter BioConfirm, and MassHunter Networked Workstation 11.0 in 2021 to comply with regulatory requirements from the EU EMEA and US FDA.

The COVID-19 crisis is affecting the industries worldwide. The global economy took the worst hit in 2020 and it is likely to continue in 2021. The outbreak has created significant disruptions in primary industries such as food & beverages, medical, energy & power, electronics & semiconductor, petroleum, and chemicals. A sharp decline in the growth of mentioned industrial activities is impacting the growth of the global IR spectroscopy market as they are the major supply and demand sources for IR spectroscopy products and solutions. The factory shutdowns, travel bans, trade bans, and border lockdowns to combat and contain the outbreak have impacted manufacturing, supply, and sales of various electronic components that are required for the manufacturing of IR spectroscopy.

Thermo Fisher Scientific Inc.; Agilent Technologies, Inc.; Shimadzu Corporation; PerkinElmer Inc.; and Bruker Corporation are the five key market players operating in the IR spectroscopy market. The listing of these five key players is derived by considering following key parameters: overall revenue, segmental revenue, brand image & industry expertise, current IR spectroscopy portfolio and related products, customer base, geographical reach, research and development investments, patents, technology integration, new product launches, partnerships, mergers & acquisitions, and other market related activities. There are several other notable players in the global IR spectroscopy market, including Hitachi High-Tech Corporation; HORIBA, Ltd.; JASCO; ZEISS International; and Lumex Instruments, which were also profiled in this report.

Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, PerkinElmer Inc., and Bruker Corporation – Prominent Market Participants in IR Spectroscopy Market

Spectroscopy is paving the path of sampling for testing purpose in varied applications including health care and medical research. In mentioned applications, spectroscopy is used as a tool for enhancing diagnostics, sensing, and disease detection. In the last few years, many advancements have evolved spectroscopes from near-IR to UV-VIS for biomedical and many other applications. Factors such as growing number of medical facilities and clinical research centers across the world to better serve the needs of patients and medical staff, and substantial investment in healthcare & pharmaceutical industries to encourage R&D in mentioned industries are contributing toward the market growth. The growth of healthcare industry is a prominent application of IR spectroscopes attributed to the rising demand for diagnosing chronic disease and for conducting medical research. With increasing number of hospital clinics, the scope of using IR spectroscopes is rising.

Portable spectrometers or handheld spectrometers enable the researchers to analyze varied samples on the go. Identification of raw materials, field analysis of samples, and forensic analysis, are among the applications of portable spectroscopes. Moreover, portable spectroscopes provide analysis capabilities similar to benchtop models. In the last few years, the IR spectroscopy has witnessed the arrival of handheld/portable laser-induced breakdown spectroscopy (LIBS) and smartphone spectroscopy concentrating on medical diagnostics for low-resource areas. The emergence and capabilities of portable instruments have increased drastically in the last 20 years, along with becoming compact and lighter. Pertaining to the factors such as developments in computing power, consumer electronics, constant R&D, and manufacturing advancement for the production of instruments are contributing toward the adoption of portable spectroscopy.

Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Shimadzu Corporation, PerkinElmer Inc., and Bruker Corporation are the five key players in the global IR Spectroscopy market. The listing of key players is derived by considering multiple factors such as overall revenue, current IR spectroscopy solution portfolio, new product launches, market initiatives, investment in technology up-gradation, mergers & acquisitions, and other joint activities. There are various other notable players in the global IR spectroscopy market ecosystem, such as Hitachi High-Tech Corporation, HORIBA, Ltd., JASCO, ZEISS International, and Lumex Instruments.

A few of the important market initiatives and product developments from the industry are mentioned below: 

2021    Agilent Technologies, Inc. released MassHunter Workstation Plus 11.0, MassHunter BioConfirm, and MassHunter Networked Workstation 11.0 in order to comply with regulatory requirements from the EU EMEA and US FDA. 

2019    Bruker Corporation announced that it has launched a standalone fixed Fourier transform infrared imaging microscope, FT-IR LUMOS II. The automated LUMOS II is developed to identify particles, to determine contaminations, and coatings and to reveal polymeric compositions.          

2019    PerkinElmer Inc. launched DA 6200 NIR analyser, an NIR spectrometer which will allow meat and olive processors to perform quality and process control more accurately.           

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Hospital Lights Market Size 2022 Industry Share, Strategies, Future Trends, Past, Present Data and Deep Analysis 2022-2028

According to our latest market study on “Hospital Lights Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type, Technology, and Application,” the market is expected to grow from US$ 5,432.01 million in 2021 to US$ 9,765.09 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028.

Hospital lights are designed specifically for use in medical institutions. They are frequently built of sturdy materials and must be able to endure regular cleaning as well as a certain level of damage. As hospitals and other medical facilities must be as clean as possible, lighting must be resistant to water and chemicals.

The notable factors driving the growth of the hospital lights market include the increasing use of LED-based lighting fixtures, government initiatives to improve energy efficiency in hospitals, and advantages of LED over conventional lighting. Furthermore, elevated government support for the adoption of energy-efficient lighting solutions in hospitals has led to the rise in the use of LED-based lighting products over traditional lighting. Ongoing developments in lighting technology are likely to create lucrative market prospects during the forecast period. UV LED lights are a more secure lighting option than traditional lights. As UV light also serves as a disinfectant, it is also used for water and air treatment to control the spreading and survival of germs, eventually killing them. This factor is further propelling the adoption of UV LED lights across hospitals.

Request for Sample Report @  

Due to robust healthcare infrastructure, Western European countries—such as Germany, France, Russia, and the UK—have witnessed a comparatively moderate decline in their production activities during the COVID-19 pandemic. The imbalance between the demand and supply sides during the lockdown phase in several European countries slightly limited the hospital light market growth in 2020 and 2021. However, government funding allocated for healthcare was redirected to frontline NHS issues, such as PPE availability and staffing, which resulted in low funds availability for the creation of new health and social care estate.

However, with the mitigation of the COVID-19 infection rate in late 2021, investments in hospitals infrastructure development and renovation have increased, which is likely to support the hospital lighting market growth. For instance, in 2021, governments in European countries announced Euro 3.7 billion to build 40 hospitals by 2030. In 2021, England built temporary hospitals to help cope with rising COVID-19 cases. In the third quarter of 2021, the redevelopment of Hospitacite Hospital Complex was started and the development of various hospital such as Lörrach Central Hospital campus, Galliera Hospital, and others is expected to drive the demand of hospital lights and eventually positively influence the hospital lights market growth.

The hospital lights market is segmented based on product type, technology, application, and geography. Based on product type, the market is segmented into troffer, surface-mounted lights, surgical lamps, and others. By technology, the hospital lights market is segmented into fluorescent technology, LED technology, and others. By application, the hospital lights market is segmented into patient wards and ICUs, surgical suites, examination rooms, and others. Based on geography, the hospital lights market is primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South and Central America.

Acuity Brands, Dragerwerk, Hubbell Incorporated, Signify Holdings, and BFW Inc are key players operating in the hospital lights market. Several important market players were analyzed during this study to get a holistic view of the market and its ecosystem.

Key Findings of Study:

In 2020, the North America region accounted for the largest share of the hospital lights market. Continuous investments by the region’s local and federal government bodies to enhance their healthcare infrastructure for the better availability and accessibility of healthcare services to all its residents and foreign individuals is rising the investment of the region on building hospitals across the region. This results in the elevated demand for efficient lighting systems in hospitals across North America. The adoption of technologically advanced hospital lighting solutions, such as LED and fluorescent lamps, helps reduce the overall operational costs, and hospitals in this region have been capitalizing on the benefits of such modern products for better efficiency across surgical and operation theaters.  Further, APAC is expected to register the highest CAGR in the hospital lights market during 2021–2028. The market growth in this region is ascribed to the presence of numerous hospital light manufacturers in several APAC countries. These manufacturers have been raising their research & development expenditure to develop new products enabled by advanced technologies. Additionally, they have increased their investments in building strategic partnerships worldwide to expand their footprints.

Prominent Market Participants in Hospital Light Market

Acuity Brands, Dragerwerk, Hubbell Incorporated, Signify Holdings, and BFW Inc.  – Prominent Market Participants in Hospital Light Market

Hospital lighting refers to lights that have been designed specifically for use in medical institutions. They are frequently built of sturdy materials and must be able to endure regular cleaning as well as a certain amount of damage. Because hospitals and other medical facilities must be as clean as possible, lighting must be resistant to water and chemicals. Significant factors driving the growth of the hospital lights market include the increasing usage of LED-based lighting fixtures, government initiatives to improve energy efficiency in hospitals, and the advantages of LED over conventional lighting. Furthermore, increased government support for the adoption of energy efficiency lighting solutions in hospitals has led in a rise in the use of LED-based lighting products over traditional lighting, which is boosting the market's overall growth. Growing developments in lighting technology are likely to create lucrative industry prospects over the forecast period.

Growing government and private investments across both developed and developing countries to build new healthcare infrastructure as well as modernize and expand existing hospital infrastructures is further expected to contribute to the growth of the global hospital lights market. Some of the major projects to mentioned include the new University Hospital of Toledo in Spain opened in 2020, Belgium started the construction of its new Grand Hospital of Charleroi in April 2019, and the construction of Narayan eye foundation private hospital in Karnataka, India. These healthcare infrastructure projects undertaken across the globe are expected to contribute to the rising demand for hospital lights over the years. Moreover, due to the global energy shortage, energy saving, emission reduction, and green development have become the common concerns of countries worldwide. According to statistics, global lighting accounts for about 20% of total power consumption. Lighting in China accounts for about 14% of total power consumption. Therefore, lighting has always been the key area of energy conversation in China and the world. Thus, the adoption of LED lights is growing rapidly and is successfully transforming the definition and scope of lighting technology. Also, the stringent rules proposed by the government and regulatory bodies of the US, Canada, and the European Union on using less efficient lighting have paved the growth path of LED lighting. And this initiatives of the governments towards adoption of LED lights will contribute to transform old hospitals building into new energy efficient hospital and thus drives the market growth.

Acuity Brands, Dragerwerk, Hubbell Incorporated, Signify Holdings, and BFW Inc. – are among the well-known players operating in the global hospital light market and are focused on product development and innovations. The above listing of key players is derived by considering multiple factors such as overall revenue, current hospital light portfolio, new product launches, market initiatives, investment in technology up-gradation, mergers & acquisitions, and other joint activities.

A few of the important market initiatives and product developments from the industry are mentioned below: 

2022    Hubbell Incorporated has been recognized as 2022 world's most Ethical Companies for the second time by Ethisphere.

2022    GE Current has completed the acquisition of Hubbell Incorporated to enhance its product portfolio. The combined GE Current and Hubbell Incorporated will be branded as Current.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Food Pathogen Testing Market Size 2022 Industry Share, Strategies, Future Trends, Past, Present Data and Deep Analysis 2022-2028

According to the latest market study on “Food Pathogen Testing Market Forecast to 2027 – COVID-19 Impact and Global Analysis - By Type (E.coli, Salmonella, Listeria, Campylobacter and Others); Technology (Traditional Technology and Rapid Technology); Food Type (Meat and Poultry, Processed Food, Fruits and Vegetables, Dairy, Cereals and Grains) and Geography,” the market was valued at US$ 5,360.94 million in 2019 and is projected to reach US$ 9,731.91 million by 2027; it is expected to grow at a CAGR of 7.9% during 2020–2027. The report highlights key driving factors and prominent market players along with their developments in the market.

 Food pathogen testing helps in monitoring the presence of any life threatening bacteria or microbes in food. The food pathogen testing is a crucial process in food industry as there are about 31 known viruses and bacteria that can cause harmful foodborne diseases. This method  is employed in every step of food production to ensure food safety. The rise in safety concerns and regulations due to increasing number of cases of food poisoning drives the growth of the market. Also, advancements in various food pathogen testing methods such as polymerase chain reaction and immunomagnetic separation and limited detection time favors the adoption of food pathogen testing among food industry.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00010911/?utm_source=medium&utm_medium=10682

The rising phenomenon of globalization is having a major impact on food systems across the world. The practices that are designed to meet the global trade demands can amplify food safety problems. The ever increasing pressure to churn out more food products has resulted in processes that compromise the existing food safety measures. Intensified food production, use of hormones and antimicrobials for promoting growth, and poor food sanity infrastructure are the key concerns in many countries. Some trade related infectious diseases come into play while matching with the innovations that are designed to serve the diversifying global palate.

 The COVID-19 outbreak was first reported in Wuhan (China) in December 2019, and since then, it has spread at a fast pace globally. Lockdowns, travel bans, and business shutdown measures implemented to mitigate the spread of infection have led to the limitations on the supplies of food & beverages products. This represents a significant loss for food pathogen testing companies.

 SGS SA, Bureau Veritas, Intertek Group Plc, Eurofins Scientific, Mérieux NutriSciences., ifp Institut für Produktqualität GmbH, ALS Limited, AsureQuality, Microbac Laboratories, and FoodChain ID Group Inc are among the well-established players in the global food pathogen testing market.

AN UPSURGE IN FOODBORNE ILLNESS OUTBREAKS– INFLUENCE THE FOOD PATHOGEN TESTING MARKET GLOBALLY

Food pathogen testing is defined as the process that helps in monitoring the presence of any life threatening bacteria or microbes in food. The food pathogen testing is mainly crucial for the food industry as there are about 31 known viruses and bacteria causing pathogens that can lead to harmful foodborne diseases. This method of testing is employed in every step of food production to ensure food safety. The rise in safety concerns and regulations due to the number of cases of food poisoning drives the growth of the market for food pathogen testing. Also, advancements in various food pathogen testing methods like polymerase chain reaction and immunomagnetic separation and limited detection time favors the adoption of food pathogen testing by various participants in the food industry.

The foodborne illness colloquially referred to as food poisoning is any type of illness which results from the spoilage of food, due to pathogenic viruses, bacteria or parasites that have the capability of contaminating the food. There is an increase of the number of people who are elderly and disproportionately susceptible to the serious outcomes of foodborne illness worldwide. Foodborne diseases comprise of a wide range of illness ranging from diarrhea to cancer. Some of the gastrointestinal issues can produce neurological, immunological and gynecological symptoms. Changes in food microorganisms can lead to the constant evolution of pathogens, development of resistance to antibiotics and change in the virulence of the known pathogens. Most of the people remain exposed to the risks of contaminated food in commercial foodservice settings due to poor hygiene.

As per the data published in two articles of the journal Emerging Infectious Diseases in 2010, the Centers of Disease Control and Prevention (CDC) have estimated that every year about 48 million people fall sick due to foodborne diseases, 1, 28,000 people are hospitalized and 3000 people lose their lives in the hands of foodborne diseases. In December, 2006 an E.coli outbreak affected about 71 customers of Taco Bell in five states. Eight of these affected people developed kidney failure and 53 people were taken to the hospitals. This outbreak was related to contaminated lettuce. Another example of foodborne illness was observed in 2015 which was considered to of the largest botulism outbreak in the last 40 years in Ohio. This outbreak caused severe illness in 29 people and one death due to respiratory failure. Consumption of improperly home-canned potatoes which was used for making potato salad was the reason behind this outbreak.

The food pathogen testing is conducted to detect such contaminations and thus to completely eliminate the chances of foodborne illnesses. It is a process that is implemented in every step of food production for the purpose of ensuring food safety and sanitation. The food pathogen testing is done using conventional cell culture standards or using new technologies like laser-based diagnostics. Salmonella, listeria and E.coli are the most common pathogens causing foodborne illnesses, food pathogen testing is concerned with. Food pathogen testing helps in monitoring the presence of any microbes or bacteria present in food that can be hazardous to the consumer. Pathogen testing is of major importance as there are 31 known virus and bacteria causing contamination that can lead to foodborne illness. Their detection and elimination is very important. Thus the rise in the outbreak of foodborne illness creates the demand for food pathogen testing.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Electroretinography Market Global Trends, Share, Growth, Analysis, Opportunities and Forecast to 2028

According to a new market research study titled ‘Electroretinography Market to 2027 – Global Analysis and Forecasts by Product and Application. The global electroretinography market is expected to reach US$ 62.72 Mn in 2027 from US$ 35.79 Mn in 2018. The market is estimated to grow with a CAGR of 6.7% from 2019-2027. The report highlights the trends prevalent in the global electroretinography market and the factors driving the market along with those that act as deterrents to its growth.

Electroretinography (ERG) is a diagnostic test used to measure the electrical response of the light sensitive cells such as the cones and the rods present in the eyes. ERG is used for detecting eye disorders such as, retinitis pigmentosa, macular degeneration, retinoblastoma, glaucoma as well as diabetic retinopathy. Compared to the other methods of eye examination, ERG offers better results as well as causes less discomfort to the patients, hence is preferred widely for the diagnosis as well as treatment of various eye disorders.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00003514/

Global electroretinography market, based on application was segmented as, clinical and research. In 2018, clinical segment held the largest share of the market, by application. Moreover, the segment is expected to grow at the fastest rate during the coming years owing to the prevalence of eye disorders as well as the rising geriatric population.

The major players operating in the electroretinography market are, LKC Technologies, Inc, Diagnosys LLC, Electro-Diagnostic Imaging, Inc., Diopsys, Inc., Roland Consult Stasche & Finger GmbH, Metrovision, Costruzione Strumenti Oftalmici, Konan Medical USA, Inc., and Welch Allyn among others. Inorganic activities such as, partnership is a prominent parameter undertaken by industry players. For instance, in April, 2018, LKC Technologies, entered into a partnership with US Retina to provide valuable and immediate access to new technologies to advance quality patient care. The developments performed by the companies are helping the market to grow in the coming years.

Diagnosys LLC and Costruzione Strumenti Oftalmici - Notable Market Players in Electroretinography Market

The players in the market are adopting various inorganic and organic developments for the individual growth and thus the growth of the market is highly dependent on them. The vital players in the electroretinography devices market focus on various growth strategies to strengthen their presence and garner major market share across the globe. Some of the notable players in the global electroretinography market include, LKC Technologies, Inc, Diagnosys LLC, Electro-Diagnostic Imaging, Inc., Diopsys, Inc., Roland Consult Stasche & Finger GmbH, Metrovision, Costruzione Strumenti Oftalmici, Konan Medical USA, Inc., Welch Allyn, and other companies. The major market players within the recent years, have been observed to invest a substantial amount towards the development of new products. This implies a bright picture on the type of strategies majorly incorporated by the market players to sustain their positions as well as to generate increased growth revenue in the electroretinography market. The global leaders in the market have been majorly adopting product launches and product up-gradation as one of the key strategy to improve its product lines in order to build up a customer centric benefits to its end users and enhance its geographic diversification.

The global leaders are expanding their activities across the world and are developing various innovative techniques to diagnose the eye conditions. For instance, during October, 2018, Diopsys, Inc. launched the Diopsys Chromatic Flash Vision Screener. It is a simple-to-use and easy-to-integrate protocol within the Diopsys ffERG / Full Field Electroretinography module. It is a new screening protocol designed to detect early retinal function changes in patients with diabetes. Additionally, another company in the electroretinography market, Konan Medical a global leader in innovative diagnostic devices for the ophthalmic industry, announced that it has attained the CE mark for its newest device, EvokeDx.

Apart from the developments for the electroretinography the players in the market are have been expanding their geographic presence by establishment of offices or new manufacturing facilities. For instance, during May, 2018, Hill Rom inaugurated its subsidiary, Welch Allyn’s new manujfacturing facility situated at Skaneateles Falls, NY. The new facility would help in better catering to the needs of the customers in the United States, hence enabling the company to hold a stronger position in the market.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Cell Therapy Instruments Market Global Trends, Share, Growth, Analysis, Opportunities and Forecast to 2028

According to our new market research study on “Cell Therapy Instruments Market to 2027 – Global Analysis and Forecast – by Product, Cell Type, Process, End User,” the market is expected to reach US$ 32,477.15 million by 2027 from US$ 12,340.03 million in 2019. The market is estimated to grow with a CAGR of 13.2% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Factors such as increasing developments in cell therapy manufacturing and rising number of approvals for cell-based therapies are expected to influence market growth. On the other hand, high cost of cell therapy production and cell therapy are expected to hinder the market growth.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00003481/

The growing adoption of cell therapies increases the production of cell therapy instruments, and the research and technological developments in medical equipment introduce various automated systems in the market. Automated manufacturing reduces the chances of contamination and increases efficacy and efficiency for human and animal-derived cells as these advantages incline toward automated manufacturing processing.

The rising number of cell therapies have shifted the production of cell therapy products from a small volume to a large volume across the world. The centralized manufacturing facility conducted in a closed and fully automated system attracts automated cell therapy instruments. Increasing time efficiency is likely to foster the use of automated cell therapy instruments. Also, the evolution of cell therapy, from an academic and clinical setting to mass production and commercialization, increases the demand for automated instruments.

Moreover, companies are entering into strategic and technological developments for automated cell therapy instruments. For instance, in July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma entered into a partnership to develop and manufacture processes in order to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve T cells' fitness and support the development of an integrated current good manufacturing practice (cGMP) compliant platform (system and software) along with reagents, consumables, and instruments. Such developments in the automated platforms will focus on entirely automated cell therapy instruments, which, in turn is likely to bolster market growth in the future.

Thermo Fisher Scientific Inc.; MERCK KGaA; Lonza; Cytiva (GE Healthcare Life Sciences); Terumo Corporation; BD; Miltenyi Biotec; STEMCELL Technologies Inc.; Sartorius AG; and Danaher Corporation (Beckman Coulter Inc.) are among the leading companies operating in the cell therapy instruments market.

The report segments global cell therapy instruments market as follows:

By Product

Consumables

Equipment

Single-Use Equipment

Cell Processing Equipment

Other Equipment

Systems and Software

By Cell Type

Human Cells

Differentiated Cells

Stem Cells

Animal Cells

By Process          

Cell Processing

Process Monitoring and Quality Control

Cell Preservation, Distribution, and Handling

Thermo Fisher Scientific Inc., and MERCK KGaA–are Notable Market Players in Cell therapy Instruments Market

Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. For instance, a person who has cancer is injected with T cells during his/her course of immunotherapy. Delivery of cell therapy instruments ranges from injections to surgical implantation using special devices. Cell therapy has applications in a large number of disorders. The most important are diseases of the nervous system and cancer. Other applications include cardiac conditions (myocardial infarction and heart failure), diabetes mellitus, bones and joints, genetic disorders, and wounds of the skin and soft tissues.

The growth of the cell therapy instruments market is mainly attributed to factors such as increasing developments in cell therapy manufacturing and rising number of approvals for cell-based therapies. On the other hand, high cost of cell therapy production and cell therapy are expected to hinder market growth.

Market leaders operating in the market have undertaken various organic and inorganic growth strategies in the cell therapy instruments market. The cell therapy instruments market majorly consists of the players such as Thermo Fisher Scientific Inc.; MERCK KGaA; Lonza; Cytiva (GE Healthcare Life Sciences); Terumo Corporation; BD; Miltenyi Biotec; STEMCELL Technologies Inc.; Sartorius AG; Danaher Corporation (Beckman Coulter Inc.) among others..

Several in organic approaches, such as product launches, and expansion in the cell therapy

instruments market, have resulted in the positive growth of the market. Likewise, inorganic

strategies such as mergers & acquisitions, and collaboration have help the company to strengthen its revenue, which allows the company to hold a strong position in the market.

Below is the list of the growth strategies done by the players operating in the cell  therapy instruments market :

March 2019           Lonza launched GS piggyBac, a versatile cell line engineering technology system which enable insertion of large fragment of DNA into transcriptionally active cells to develop therapeutic cell lines.

April 2019  STEMCELL technology has received USD 45 million aid from the government of Canada to expand its state of art facility and scale up its instruments and reagent business in cell therapy market.

December-2019    Sartorius acquires a major portion of cell culture media specialist Biological Industries based in Israel. This will expand the cell therapy instruments business of Sartorius in Middle East region.

April 2018  BD launched new BD FACSymphony S6 cell sorter which offers a better cell population sorting to analyze cell phenotypes for multiomics and immunology research purposes.

September 2017   Terumo BCT signed partnership agreement with Mallinckrodt in order to develop and distribute white blood cell processing system called THERAKOS CELLEX Photopheresis System

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Private LTE market is expected to reach US$ 8,507.2 million by 2028

According to the new research report, titled “Private LTE Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Component (Solution and Services); Type (FDD and TDD); End-user (Manufacturing, Energy & Utilities, Healthcare, Transportation, Mining, and Others), and Geography” published by The Insight Partners, the market is expected to reach US$ 8,507.2 million by 2028, registering a CAGR of 13.6% during 2021–2028.  

Private LTE Market in APAC is Expected to Grow at Highest CAGR    

The private LTE market in the APAC is further segmented into Australia, India, China, Japan, and South Korea. The region's oil & gas industry is anticipated to witness an increase in mergers & acquisitions and final investment decisions. Growth in the manufacturing industry in Asian countries, such as China, India, Japan, South Korea, and Taiwan, would further create a positive impact on the adoption of private LTE.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00003471/

China and Japan are the most significant manufacturing economies producing automobiles, IT products, and electronic products. The market growth of private LTE in this region is due to factors such as the rise in M2M communications, increase in smartphone penetration, which is supported by the penetration of IoT platforms across various industries such as healthcare, transportation, and manufacturing. This leads to the increased demand for private IoT networks, which enable companies to integrate different devices for increased reliability and security. Many of the economies of the region are looking for digital applications such as autonomous vehicles, smart cities, and IoT to empower its economy further. The investors are to avoiding high-tech costs investment in the US and are diverting toward the APAC region to invest on big business opportunities, which includes 5G technology with the acceleration in the adoption of digital transformation across various countries in the region.    

Key findings of the study:

China dominates the private LTE market in 2020. China has the largest manufacturing sector in the world, with presence of diverse industries. The presence of robust manufacturing base is a key factor for the growth of the private LTE market. The government of China has introduced an initiative named as “Made in China 2025,” which drives the growth of manufacturing sector. The major manufacturing industries of China include automotive, machinery manufacturing, energy, and steel. Thus, the implementation of private LTE is anticipated to boost the production process of the plant. Companies such as Huawei along with Jishi Media has built a 700 MHz LTE network. The companies’ new system is capable of streaming real-time HD video captured using infrared ecological data, camera traps, and footage from road checkpoints & fire safety cameras. The system supports tracking of ranger patrols and video calls, which enable the conservationist to have remote access to the real-time data. Moreover, in November 2018, China Unicom and Nokia deployed private LTE network for the smart manufacturing services at China established BMW plant. The 4G LTE network of China Unicom will give low-latency support to help smart manufacturing activities at plant.

India is anticipated to be a fastest growing country in Asian market in private LTE market. The existence of large number of telecom operator in the country with efficient as well as economic data plans is driving the growth of telecom industry in the country. The topmost telecom service providers in India are Vodafone, Aircel, Idea Cellular, Mahanagar Telephone Nigam Limited (MTNL), Bharti (Airtel), Bharat Sanchar Nigam Limited (BSNL), Tata Teleservices, Reliance, Tata Communications, and Tata Teleservices Maharashtra (TTML). Recently, Bharti Airtel announced its partnership with Nokia for providing private LTE network to various enterprises such as information technology enabled services (ITES), banking, media and services, financial services, and insurance (BFSI), manufacturing and distribution. At present, in India, around 330 companies are making investments in mobile networks based on 5G/LTE in the form of pilot deployments, trials, and commercial network launches as well as investment in licenses. This investment in would facilitate deployment of 5G networks/private LTE. Moreover, at a same time frame, 150 companies have installed 5G networks, private LTE, and spectrum

.

CommScope, Huawei Technologies, Cisco Systems, Sierra Wireless, Verizon – Prominent Market Participants in Private LTE Market

The advent of private LTE has brought a host of new use cases for industrial and residential uses that are anticipated to be enabled by the evolving networks over the course of years. Fixed Wireless Access (FWA) for residential use and distributed cloud for industries could be examples of these kind. A market competing with fixed broadband access is driving a need for higher bandwidth. The objective is to provide fiber-like speeds that can meet the demand for residential streaming services, such as TV and video. Typical data speed demand ranges from 100 to 4,000 Mbps.

In addition to growth of private LTE, new 5G industry use cases are projected to provide around US$ 700 billion of growth opportunity to the service providers by 2030. With broadening use of 5G and private LTE- manufacturing, energy and utilities, automotive, agriculture, and public safety among others are few significant arenas expected to hold substantial market share. With rising demand of improvised video services, connected vehicles, real-time automation, and augmented reality/virtual reality remote operations, the adoption rate of 5G and private LTE will grow exponentially.

CommScope, Huawei Technologies, Cisco Systems, Sierra Wireless, and Verizon. The above listing of key players is derived by considering multiple factors such as overall revenue, current private LTE solution portfolio, new product launches, market initiatives, investment in technology up-gradation, mergers & acquisitions, and other joint activities. There are various other notable players in the global virtual production market ecosystem, such as Ericsson, Samsung, Future Technologies, NetNumber Inc., and Start Solutions.

A few of the important market initiatives and product developments from the industry are mentioned below: 

2021    Cisco and PLDT partnered to develop and design a fully automated software 5G-ready IP transport network infrastructure.  The partnership aimed to build and deploy automated, highly reliable, highly scalable, seamless internet service      

2020    Huawei’s 5G RAN gNodeB and LTE eNodeB have passed 3GPP’s Security Assurance Specifications (SCAS) test that was conducted by Network Equipment Security Assurance Scheme (NESAS). The tests include network product general security, air interface security, and basic vulnerability testing, such as data and information protection, air interface ciphering and integrity protection, robustness, and fuzz testing.         

2019    CommScope’s Ruckus CBRS portfolio and Attabotics’ 3D robotic supply chain automation system were demonstrated as part of Microsoft Azure capabilities for private LTE networks during Microsoft Ignite     

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Data Protection as a Service (DPaaS) Market is expected to reach US$ 94.3 Bn in 2027, registering a CAGR of 29.1% during the forecast period 2019-2027

According to the new research report published by The Insight Partners, titled “Data Protection as a Service (DPaaS) Market — Global Analysis and Forecast to 2027”, the global data protection as a service market is expected to reach US$ 94.3 Bn in 2027, registering a CAGR of 29.1% during the forecast period 2019-2027.

In 2018, North America was estimated to account to hold the largest market share, growing at a CAGR of 26.7%.

The data protection as a service market is majorly driven by an increasing number of cyber-attacks and adoption of security solutions, increasing demand for secure transaction in the BFSI sector, and others. Other factors responsible for boosting the business growth of DPaaS market is the integration of AI and other advanced technologies for alerting and pattern-based monitoring. The rapidly changing nature of businesses requires consistent changes in technology and services. Also, the rapid digitalization among SMEs is expected to provide substantial growth opportunity to the key players in this market. A large number of start-ups have been entering the marketplace with their innovative DPaaS by integrating artificial intelligence and other advanced technology into them.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00003295/

In North America, the US-led data protection as a service market. The US is the most significant economy in the world, and one of the most important economy as well. The economy is also a step ahead when it comes to adoption of new technologies as well as the adoption of advanced solutions is quite high. Factors such as growing digitization of business processes and rising demand of advanced data protection services among enterprises to ensure efficient and risk-free business operations are contributing substantially towards the growth of DPaaS market in the country.

In the Asia Pacific, China led data protection as a service market. China being an industrial and technology hub, attracts several cybercriminals. This is where DPaaS play a vital role in this region. Huge population, presence of e-commerce giants, growing services sector, and rising demand for smart business solutions offers a suitable environment for the adoption of DPaaS in China. China is transitioning from its image of being a low-cost labor country by investing heavily in digital transformation to acquire a dominant position in the global technology market landscape. Also, the Cyber Security Law of China, also known as the China Internet Security Law, aims to increase cybersecurity, national security, and safeguard cyberspace sovereignty, among other aspects. This law serves as a “Basic Law” in the cybersecurity space.

Key findings of the study:

APAC is the fastest-growing region in data protection as a service market. Earlier, cybercrimes in APAC have been growing at a substantial rate owing to penetration of connected devices, digitization of essential services, investments in the ICT sector, business process automation, and other related developments. In addition, the region is becoming a new target of cybercriminals. In 2017, it was found that nearly 50% of the companies that face data breaches and security threats were SMEs. All the above-mentioned factors drive the growth of the DPaaS market in this region. This has resulted in higher demand for DPaaS in the region.

The demand for DPaaS is primarily influenced by numerous economic and non-economic factors. The BFSI, Government, and healthcare sector present a larger demand as compared to other sectors during the forecast period. Potentially, Backup as a Service (BaaS) by service type in 2018 led the data protection as a service market whereas; Disaster Recovery as a Service (DRaaS) is expected to be the fastest-growing application during the forecast period 2019-2027 growing at a high CAGR value.

AMAZON WEB SERVICES, INC., COMMVAULT, EMC CORPORATION, HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP, AND IBM CORPORATION- NOTABLE MARKET PARTICIPANTS IN DATA PROTECTION AS A SERVICE INDUSTRY

Data protection as a service is a cloud-based or web-delivered service to protect data assets residing on the cloud platform. Organizations generally utilize this service to enhance their network security and improve security for effective data management on the cloud. With the growing information flow, there is a constant demand for advanced data security software and services. There is a rising demand for solutions & services to reduce complexities and maintenance in terms of large data volumes. Data protection as a service help organizations to effectively and efficiently tackle security issues by offering cost-effective cloud services. It is a multi-tenant model which enables management of various services through a single portal. Growing demand for privacy and data security across all organizations globally is playing a major role in driving market growth.

The most prominent market players in correspondence management system market are Amazon Web Services, Inc., Commvault, EMC Corporation, Hewlett Packard Enterprise Development LP, and IBM Corporation -among others for a considerable share of the market owing to their product offerings to the data protection as a service market.

Organizations seek advanced cloud features for high scalability and better management in their services. The increasing demand for cost-effective data protection as a service and disaster recovery services have enhanced the growth avenue of the market.

Market leaders are involved in taking up a various market initiative such as expanding footprint across the world and meet the growing demand of its customers, focusing towards product enhancements by implementing advance technologies and signing partnership, contracts, joint ventures, funding, and inaugurating new offices across the world to maintain brand name globally. For instance, in 2019, EMC Corporation announced improved capabilities to the Dell EMC Data Domain and Integrated Data Protection Appliance (IDPA) portfolio of backup storage appliances build to provide businesses flexibility and value with expanded multi-cloud capabilities. In the same year, one more initiative in undertaken by Amazon Web Services. The company has been certified by the Australian Cyber Security Centre (ACSC) to host protected data and to provide assurance to Australian Government agencies with data security.

The data protection as a service market is highly fragmented with several well-established as well as local players operating in the market space. It has resulted in high competition among them. Also, the market entry barriers are low, thus, attracting several emerging players.  Some of the recent developments in the military logistics market are mentioned below:

2019    Amazon Web Services has been certified by the Australian Cyber Security Centre (ACSC) to host protected data and to provide assurance to Australian Government agencies with data security.  

2018    McAfee entered in endpoint detection and response (EDR) space and announced cloud and unified data protection offerings that surge visibility across the whole ecosystem. McAfee’s MVision EDR works on the cloud to enable analytics and automation.    

2018    IBM Corporation announced the new IBM Cloud Backup, which enables backup needs. The solution is built for backup and disaster recovery. It secures data with enterprise-grade encryption.  

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Healthcare CMO market estimated to grow with a CAGR of 12.2% from 2019-2027

According to a new market research study titled ‘Healthcare CMO Market to 2027 – Global Analysis and Forecasts by Service and Geography. The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018. The market is estimated to grow with a CAGR of 12.2% from 2019-2027. The market is expected to grow due to increasing contract manufacturing of the active pharmaceutical ingredients (API) for the pharmaceutical contract manufacturing services.

Contract manufacturing organization (CMO) also known as contract development and manufacturing organization is a company that serves several other companies in the medical devices as well as pharmaceutical and biopharmaceutical sector with comprehensive services from development, manufacturing to packaging. These services are outsourced by various OEM players in the business in order to help with the scalability, and save marginally on production costs.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00003263/

Global healthcare CMO market, based on services was segmented as, pharmaceutical contract manufacturing services and medical device contract manufacturing services. The pharmaceutical contract manufacturing services is further classified as active pharmaceutical ingredients (API), final dosage form manufacturing and packaging market. Similarly, the medical device contract manufacturing services is divided into outsourcing design, device manufacturing and final good assembly markets. In 2018, the pharmaceutical contract manufacturing services segment held the largest share of the market, by service. Also, the pharmaceutical contract manufacturing services segment is expected to witness fastest growth at a fastest CAGR of 12.6% during 2019 to 2027.

The major players operating in the healthcare CMO market:

Royal DSM, Catalent, Inc, Boehringer Ingelheim International GmbH, Recipharm AB (publ), Fareva, Lonza, Piramal Enterprises Ltd, Dr. Reddy’s Laboratories Ltd., Almac Group, FAMAR Health Care Services

The report segments the global healthcare CMO market as follows:

Global Healthcare CMO Market – By Service

Pharmaceutical Contract Manufacturing Services

Active Pharmaceutical Ingredients (API) Manufacturing

Final Dosage Form Manufacturing

Packaging

Medical Device Contract Manufacturing Services

Outsourcing Design

Device Manufacturing

Final Goods Assembly

Catalent Inc and Lonza - Notable Market Players in Healthcare CMO Market

The healthcare CMO is a well-established market in nature with consisting of the good and enormous number of players, having considerable revenue in the market. Most of the companies operating in the healthcare CMO market are offering their services to the pharmaceutical and medical device companies in the North American, European, Asia Pacific, Middle East, African and South and Central American regions. The CMO have expanded their production facilities in these regions and also have a tough competition by the existing players of these regions.

The most notable market participants are Royal DSM, Catalent, Inc, Boehringer Ingelheim International GmbH, Recipharm AB (publ), Fareva, Lonza, Piramal Enterprises Ltd, Dr. Reddy’s Laboratories Ltd., Almac Group, and FAMAR Health Care Services occupying a considerable share of the market owing to their service offerings to the companies.

Market leaders are involved in activities such as, acquisitions & mergers and service launches. For instance, In June, 2018, Lonza expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in North America. And the other instance took place in April, 2018 Almac Group expanded its US commercial packaging capabilities at its Audubon, PA facility.

The market has experienced several service launches, expansion, mergers and acquisition, and other developmental activities that has resulted into organic growth strategies for the respective companies.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Pharmaceutical Fill and Finish Outsourcing Market expected to grow at a CAGR of 6.1% from 2021 to 2028

According to our latest study on “Pharmaceutical Fill and Finish Outsourcing Market Size and Forecast to 2028 – COVID-19 Impact and Global Analysis – by State of Finished Product and Content,” and Geography. The market is projected to reach US$ 4,010.51 million by 2028 from US$ 2,657.04 million in 2021; it is expected to grow at a CAGR of 6.1% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

With the onset of COVID-19, the demand for contract development and manufacturing organizations (CDMOs) services is skyrocketing, as CDMOs have stretched themselves to meet the needs of biopharmaceutical and pharmaceutical companies during the crisis. Contract Development and Manufacturing Organizations (CDMOs) offer fill and manufacturing services such as drug development and clinical supply, commercial active pharmaceutical ingredient (API) and drug manufacturing, and packaging to pharmaceutical companies. Such services allow pharmaceutical companies to reduce their development and manufacturing costs, timelines, and capital investments. The pre-pandemic situation resulted in trends wherein most pharma-CDMO relationships remained transactional. However, during the onset of the pandemic, the situation was reversed. Pharma companies suddenly faced challenges in producing millions of doses to match the unprecedented demand from the market. Therefore, the largest source of additional capacity was CDMOs. For instance, Pfizer, Moderna, and AstraZeneca officially announced their partnership with several CDMOs such as Catalent, Emergent Biosolutions, and Lonza after announcing significant expansions of their manufacturing plants.

Download Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00017482/

Liquid Segment to Hold Largest Share of Pharmaceutical Fill and Finish Outsourcing Market Analysis During 2021–2028

Based on content, the pharmaceutical fill and finish outsourcing market is segmented into

organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances. The organic substances isolated from microorganism’s segment held the largest share of the market in 2020 and is projected to continue a similar trend during the forecast period. On the other hand, the organic substances isolated from the animal origin segment is estimated to register the second highest CAGR in the market during the forecast period. Currently, pharmaceutical companies are shifting their focus toward outsourcing companies for gaining their microbial manufacturing product expertise and launching their products from labs to market. This is primarily due to microbial-derived products carrying the second-largest market of biologics. For matching such unprecedented demand, there is a need for CDMOs microbial outsourcing.

Abbott, Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Piramal Enterprises Ltd, MabPlex International Ltd, Wockhardt, Cytovance Biologics, Thermo Fischer Scientific Inc. (Patheon N.V.), and Boehringer Ingelheim International GmbH are among the leading companies operating in the global pharmaceutical fill and finish outsourcing market.

The report segments the pharmaceutical fill and finish outsourcing market as follows:

Based on state of finished product, the pharmaceutical fill and finish outsourcing market is segmented into solids, semi-solids, and liquids.

By content, the market is segmented into organic substances isolated from animal origin, organic substances isolated from microorganisms, and inorganic substances.

By Geography

Based on Geography, North America comprises of key countries such as United States, Canada, and Mexico. Additionally, Europe comprises of France, Germany, UK, Spain, Italy, and the Rest of Europe for analysis. Asia Pacific comprises of China, India, Japan, Australia, South Korea, and The Rest of APAC countries for analysis. MEA region comprises of Saudi Arabia, UAE, South Africa, and the Rest of MEA countries for analysis. Furthermore, South and Central America comprise of Brazil, Argentina, and the Rest of South and Central America countries.

Boehringer Ingelheim International GmbH And Abbott Laboratories - Notable Market Players in Pharmaceutical Fill and Finish Outsourcing Market

The global pharmaceutical fill and finish outsourcing is more inclined towards contract manufacturing. There are several types of contract manufacturing for pharmaceuticals as well as for biotechnology products that involve partial contract manufacturing and complete manufacturing of pharmaceuticals and biotechnology products.

 The pharmaceutical fill and finish outsourcing market is majorly comprised of top players involving Abbott, Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Piramal Enterprises Ltd, MabPlex International Ltd, Wockhardt, Cytovance Biologics, Thermo Fisher Scientific Inc. (Patheon N.V.), and Boehringer Ingelheim International GmbH.

 The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Dried honey market is projected to reach US$ 1,253.44 million by 2028 from US$ 723.18 million in 2021

Dried honey market factors fueling the market growth, estimation and forecast of revenue, and identification of significant market players and their key developments

The scope of our recent study titled "Dried Honey Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Form (Powder and Granules), Category (Organic and Conventional), and Application (Food & Beverages, Personal Care, and Pharmaceuticals & Nutraceuticals)" includes the description of factors fueling the market growth, estimation and forecast of revenue, and identification of significant market players and their key developments. It also includes providing market share analysis.

The dried honey market is projected to reach US$ 1,253.44 million by 2028 from US$ 723.18 million in 2021. It is expected to grow at a CAGR of 8.2% from 2021 to 2028.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00017405/

Dried honey is used in various applications, primarily in the food and beverages industry. The product is used as a natural alternative to refined sugar. Honey has been known for its antimicrobial and antioxidant properties, which has led to its increased use in personal care products. Honey helps reduce low-density lipoproteins in the body, along with mitigating health risks concerning heart diseases and blood pressure; moreover, the ingredient has been traditionally used as a natural aid for coughing. The health benefits associated with honey have led to its increased use in the nutraceuticals industry.

Based on form, the dried honey market is segmented into powder and granules. The powder segment held a significant market share in 2020. Powdered honey is a dehydrated form of natural honey with less than 2% of the liquid content of the standard liquid form. The powder form is dehydrated, which leads to a significantly longer shelf life and is more suitable for use in various recipes. Thus, despite the fact that it may not have the same nutritional benefits as raw honey, powder honey is considered a better alternative for baking. It can be added to a cup of tea, coffee, or green tea, and it is preferable over artificial sweeteners.

The dried honey market is segmented into five main regions—North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South and Central America (SAM). Asia-Pacific held the largest share of the market in 2020, while the Middle East and Africa market is expected to register the highest CAGR during the forecast period. Honey is highly consumed in countries such as China and India. The rising demand for dried honey as a natural sweetener across the food & beverages sector in the region is one of the top drivers for the dried honey market. Dried honey is easy to handle and store ad it is not sticky, unlike liquid honey. In India, the popularity of organic honey products is substantially increasing owing to their perceived benefits over conventional ones. Moreover, due to the antibacterial and hydrating properties of honey, manufacturers of personal care products across Asia-Pacific are widely employing dried honey in their products.

Impact of COVID-19 Pandemic on Dried Honey Market

The COVID-19 pandemic has negatively impacted various industries due to lockdowns, travel bans, manufacturing shutdowns, and supply shortages. The food and beverages industry faced operational difficulties due to supply chain disruptions, and labor and raw material shortages. However, as the governments of various countries introduced relaxation in social restrictions and accelerated vaccination drives, the food and beverage industry is recovering from its losses. Moreover, an increased inclination toward having healthy and immunity-boosting food and beverages during the COVID-19 outbreak is boosting the growth of the dried honey market.

The report segments the dried honey market as follows:

Based on form, the dried honey market is segmented into powder and granules. Based on category, the market is segmented into organic and conventional. Based on the application, the market is segmented into food & beverages, personal care, and pharmaceuticals and nutraceuticals. Based on geography, the dried honey market is segmented into North America, Europe, Asia Pacific (APAC), the Middle East and Africa (MEA), and South and Central America (SAM).

Increasing Consumer Inclination Towards Wellness and Organic Products is Expected to Boost Market Growth

Dried honey is basically dehydrated honey primarily utilized as a sugar alternative. It is a healthier option, mainly for baked goods. It is further known as a honey powder or honey crystal. The global dried honey product market is anticipated to grow at a significant growth rate, attributed to the steady growth of the food and beverages industry and personal care & cosmetic industry worldwide over the forecast period. Factors such as increasing use in the bakery and confectionary industry, cosmetics and soap industry, development of value-added products from honey, usage in medicine like products, food ingredients, and its growing use as a food are driving the growth of the global dried honey market.

Consumers are highly concerned about the food they consume. They are paying more attention to the product labels and the ingredients used in processed food products. Organic food products are becoming increasingly popular, owing to their perceived health benefits. Ingredients in organic products come from organically certified farms that follow strict farming practices. Organic products are free of pesticides, chemical fertilizers, and genetically modified organisms (GMOs) that increase their appeal among consumers, who are ready to pay high prices for them. The rising popularity of organic and all-natural products opens profitable growth opportunities for natural sweeteners, such as dried honey. Manufacturers offer organic dried honey produced using pollen from organically grown plants, and the bees are not treated with chemical miticides. Furthermore, clean-label food products are gaining huge traction among consumers. These products contain 100% natural and simple ingredients. Thus, the growing preference for organic and all-natural food products is expected to provide lucrative opportunities for the dried honey market in the coming years.

A few players operating in the Dried Honey market are Best Ground International; ASR GROUP; Hoosier Hill Farm; Associated British Foods plc; Norevo; Specialty Products and Technology, Inc.; Spice Alliance, LCC; SWEET HARVEST FOODS; ADM among few others.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

CBD gummies market was valued at US$ 2,133.48 million in 2021 and is projected to reach US$ 12,182.21 million by 2028

The scope of our recent study, titled "CBD Gummies Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Category (Sugar-Free and Conventional) and Distribution Channel (Specialty Stores, Online Retail, and Others)," includes the description of factors fueling the market growth, estimation and forecast of revenue, and identification of significant market players and their key developments, along with market share analysis.

The CBD gummies market was valued at US$ 2,133.48 million in 2021 and is projected to reach US$ 12,182.21 million by 2028. It is expected to grow at a CAGR of 28.3% from 2021 to 2028.

CBD gummies are infused with CBD oil, which has anti-inflammatory, neuroprotective, anti-anxiety, and analgesic effects. They help reduce the pain from athletic injuries, induce calmness, and relieve stress and anxiety. People see the effects of CBD gummies after around 30 minutes to 1 hour of consumption. CBD gummies are widely available forms of CBD products. They are available in a variety of flavors. The manufacturers are also launching sugar-free, organic, vegan, GMO-free, and gluten-free CBD gummies to cater to emerging consumer trends. This factor is projected to open significant growth opportunities in the CBG gummies market over the forecast period.

Download Sample Report at @ https://www.theinsightpartners.com/sample/TIPRE00017402/ ?utm_source=article&utm_medium=10682

Based on category, the CBD gummies market is segmented into sugar-free and conventional. The conventional segment held a significant share in the global CBD gummies market in 2020. The sugar-free segment is projected to grow at a faster CAGR over the forecast period. Conventional gummies are widely available across supermarkets and hypermarkets, pharmacy stores, and drug stores. Moreover, they are easy to manufacture as the raw materials are easily available. However, the conventional CBD gummies can experience reduced popularity as consumers are becoming health-conscious.

Moreover, consumers have a wide range of healthier alternatives for conventional gummies, which can hinder the segment's growth over the forecast period. However, local manufacturers may still use conventional raw materials as they are affordable and easily accessible. This factor can positively drive the conventional CBD gummies market.

Based on geography, the CBD gummies market is segmented into – North America, Europe, and the Rest of the World. North America held the largest share in the global CBD gummies market in 2020. There is high awareness about CBD products in the US. According to the 2019 Gallup Poll, 14% of the surveyed American consumers use CBD products. This number is projected to grow in the future as the awareness regarding the health benefits of CBD is increasing dramatically in countries like the US and Canada. Moreover, many American celebrities and influential personalities are using and promoting CBD products. For instance, Kim Kardashian—an American celebrity and businesswoman with a large number of followers on social media—stated that she consumes CBD gummies regularly to have a proper sleep. This factor is also expected to favor the growth of the CBD gummies market across North America in the coming years.

Key Market Players:

A few players operating in the CBD gummies market are Dixie Brands; Aurora Cannabis Inc.; Canopy Growth Corporation; Sunday Scaries.; Diamond CBD; CBD American Shaman; CV Sciences, Inc.; Medix CBD; CBDFx; and Elixinol among others.

Impact of COVID-19 Pandemic on CBD Gummies Market

The COVID-19 pandemic has negatively impacted various industries due to lockdowns, travel bans, the shutdown of manufacturing units, and supply shortages. The food & beverages industry faced operational difficulties caused by disruption of supply chains, labor shortage, and shortage in raw material supply. Additionally, lockdowns and border restrictions hampered product innovation and collaboration opportunities in the market. The CBD gummies market witnessed the mixed impact of the pandemic. As people stayed in their homes due to the work from home mandates, they focused more on their physical and mental well-being. They preferred healthier foods, beverages, and dietary supplements that boosted their mental health. This factor leveraged the demand for CBD gummies. However, due to operational difficulties, many manufacturers suffered from a shortage of raw materials and labor, which negatively impacted their profits. However, the global marketplace is recovering from the losses, and the manufacturers are overcoming the demand and supply gaps as they are permitted to operate with full capacity. A strong foothold of e-commerce platforms in various regions such as North America, Asia-Pacific, and Europe also supported the growth of the CBD gummies market as these platforms offered uninterrupted services to the consumers even during the initial months of the pandemic.

The report segments the CBD gummies market as follows:

Based on category, the CBD gummies market is bifurcated into sugar-free and conventional. In terms of distribution channel, the market is segmented into specialty stores, online retail, and others. Based on geography, the CBD gummies market is segmented into North America, Europe, and the Rest of the World.

High Influence of Social Media and Celebrities on People to Boost Market Growth

CBD gummies are infused with cannabidiol and has less than 0.3 percent tetrahydrocannabinol (THC). Cannabidiol or CBD is a medicinal compound extracted from hemp plants that are antagonistic in behavior. Therefore, these gummies have pharmaceutical applications for relieving stress, pain, anxiety, depression, insomnia, inflammation, and many more. CBD gummies are also used for the treatment of epilepsy. These gummies come in a variety of forms, tastes, colors, and cannabidiol concentrations.

Social media is playing a crucial role in changing the lifestyles of people. Over the past few years, the number of social media users has increased dramatically owing to the rising penetration of the internet and smartphones. People are largely influenced by social media influencers and celebrities and try to follow them. Brands are getting benefitted due to the growing influence of social media and celebrities on people. CBD products are heavily promoted by celebrities on social media platforms. Some of the influential personalities such as Seth Rogan, Snoop Dogg, Olivia Wilde, Jay Z, Danny DeVito, Wiz Khalifa, and Willie Nelson are promoting the use of CBD. Most celebrities have chosen to either launch their own brand or invest in a cannabis-based business. Willie Nelson, for example, has his own cannabis company, Willie's Reserve. Pre-rolled joints, dried flowers, edibles, and oil concentrates are among the few items he sells on his website. Celebrities and businesswomen such as Kim Kardashian and Martha Stewart use CBD gummies to improve their sleep. Kim stated that she regularly uses CBD gummies to help her to get proper sleep. On the other hand, Martha Stewart also mentioned that she consumes CBD gummies and CBD drops from her own brand. These celebrities have a large number of followers on social media platforms. Thus, the rising promotion of CBD products including CBD gummies by celebrities and a high influence of celebrities on people are expected to drive the CBD gummies market in the future.

A few players operating in the CBD gummies market are Dixie Brands; Aurora Cannabis Inc.; Canopy Growth Corporation; Sunday Scaries.; Diamond CBD; CBD American Shaman; CV Sciences, Inc.; Medix CBD; CBDFx; and Elixinol among others.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Colloidal Silica Market expected to grow at a CAGR of 5.8% during 2021–2028

The scope of our recent study on “Colloidal Silica Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product Type (Alkaline, Acidic, Modified, and Ordinary) and Application (Pulp and Paper, Building and Construction, Paints & coatings, Electronics and Semiconductors, Pharmaceuticals, Investment Casting, and Others)” consists of the factors fueling the market growth, revenue estimation and forecast, and market share analysis, along with the identification of significant market players and their key developments.

The colloidal silica market is projected to reach US$ 1,121.22 million by 2028 from US$ 757.80 million in 2021; it is expected to grow at a CAGR of 5.8% during 2021–2028. Colloidal silica is stable at a pH range of 8–10.5 and carries an anionic surface charge stabilized, usually with sodium or ammonium. Some grades of ordinary colloidal silica may have silicon atoms replaced with aluminate ions, allowing enhanced stability in a wider pH range. Standard colloidal silica has applications in various industries, such as paints & dyes, textiles, investment casting, and building & construction. It can also produce other types of colloidal silica through surface modification. The growth of various end-use industries is propelling the market growth for colloidal silica.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00017383/ ?utm_source=article&utm_medium=10682

The global colloidal silica market is segmented into five main regions— North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South and Central America. In 2020, Asia Pacific accounted for the largest share of the market and is expected to grow at the highest CAGR during the forecast period. Colloidal silica (Silica Sol) is also used in various industries, including textile, papermaking, coatings, refractory, ceramics, and foundries. Furthermore, consumption of colloidal silica is growing fast in applications, such as pulp and paper mills and paints & coatings. The paints & coatings industry in Asia Pacific is well established but affected by global economic conditions.

The paints & coatings industry in Asia Pacific is expected to grow at a CAGR of 4.4% from 2018 to 2023 in volume and 5.3% in value, as per American Coatings Association. One of the most significant characteristics of the paints & coatings industry in Asia Pacific dictates the growth in demand based on the trend of GDP growth. As Asia Pacific consists of developing economies with GDP growing at an aggressive rate, the paints & coatings industry in the region is expected to witness massive growth over the forecast period. Paints & coatings are one of the major applications for colloidal silica; therefore, the growth in the application industry is expected to benefit the colloidal silica market in Asia Pacific over the forecast period.

Impact of COVID-19 Pandemic on Colloidal Silica Market:

In the pre-pandemic period, the colloidal silica market was mainly driven by the high demand from various application sectors, including building and construction, investment casting, and textile. However, due to the outbreak of COVID-19 in 2020, many industries faced unprecedented challenges. The textile industry faced a decline in growth due to the slowdown in manufacturing activities. The COVID-19 pandemic disturbed the manufacturing processes due to restrictions imposed by government authorities in various countries. There was a decrease in demand for textiles from subsequent end-use industries, such as construction, mining, automotive, and consumer goods, owing to disruption of supply chains, raw material shortage, and a temporary halt in business operations. The textile industry is one of the major application areas of colloidal silica, and the disruption in this industry significantly impacts its demand. These factors adversely affected the colloidal silica market in 2020.

Global Colloidal Silica Market Breakdown – by Region

The report includes the segmentation of the global colloidal silica market as follows:

By product type, the colloidal silica market is segmented into alkaline, acidic, modified, and ordinary. By end user, the market is segmented into pulp and paper, building and construction, paints and coatings, electronics and semiconductors, pharmaceuticals, investment casting, and others. Based on geography, the market is broadly segmented into North America, Europe, Asia Pacific (APAC), the SMiddle East & Africa (MEA), and South and Central America. The market in North America is further segmented into the US, Canada, and Mexico. The colloidal silica market in Europe is subsegmented into Germany, France, the UK, Italy, Russia, and the rest of Europe. The market in Asia Pacific is subsegmented into China, India, Japan, Australia, South Korea, and the rest of Asia Pacific. The colloidal silica market in the Middle East & Africa (MEA) is further segmented into South Africa, Saudi Arabia, the UAE, and the rest of MEA. The market in South and Central America is subsegmented into Brazil, Argentina, and the rest of South and Central America.

INCREASE IN DEMAND OF WASTEWATER TREATMENT BOTH IN INDUSTRIAL AND RESIDENTIAL SECTOR INFLUENCE THE MARKET GLOBALLY

Colloidal silica is a highly versatile material used to enhance the properties of many products from various industries such as building & construction, food & beverages, and pulp & paper. Colloidal silica is used for enhancing oxygen barrier properties, improving ink absorption, and forming strong hydrogen and ionic bonds with fibrous and granular material in binder applications. These bonds are chemically inert and thermally stable, making them especially useful for insulation boards, catalysts, specialty coatings, vacuum-formed refractories, and investment casting slurries.

Colloidal silica adheres well to many surfaces via hydrogen and ionic bonding. The silica particles in colloidal silica increase friction coefficient when applied to the surface, making it suitable for use in industrial and architectural coatings, polishing slurries, flooring, and paper and cardboard. Colloidal silica is utilized for flocculants application due to its availability in various grades with cationic and anionic sol charges. Colloidal silica is an excellent flocculants for insulation board, beverage fining, and paper drainage and retention due to its high binding properties. Versatile applications of colloidal silica have resulted in consistent demand from chemical and other end-use industries that are anticipated to grow over the forecast period. Therefore, the growth of end-use industries drives the market for colloidal silica. 

In 2020, Asia-Pacific accounted for the largest share in the global colloidal silica market. Steady growth in the population coupled with the growth in industrialization in the countries increases colloidal silica usage in manufacturing industries. China is highly developing country with large scale manufacturing and industrialization which, in turn creates lucrative opportunities for the colloidal silica market in the region. Further, growing dominance as well as higher production rate of automotive, and the easy availability of raw materials boost the growth of the colloidal silica market in Asia-Pacific.

Some of the major key players operating in the global colloidal silica market include Cabot Corporation; Ecolab, Inc.; Evonik Industries AG; FUSO CHEMICAL CO.; Jinan Yinfeng Silicon Products Co. Ltd; Nissan Chemical Corporation; Nouryon; PPG Industries, Inc.; The Dow Chemical Company; and W.R. Grace & Co.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Viral Antigens Market expected to grow at a CAGR of 11.0% during 2020–2027

According to our latest study on “Viral Antigens Market Forecast to 2027 –COVID-19 Impact and Global Analysis – by Component [Influenza Viral Antigens, Coronavirus Antigens, Zika Virus Antigens, Ebola Virus Antigens, Dengue Virus Antigens, Herpes Simplex Virus (HSV) Antigens, Rotavirus Viral Antigens, Hepatitis A-E Virus Antigens, Measles Virus Antigens, Mumps/Parotitis Virus Antigens, and Others], Technique [ELISA, Immunoassay, Hemagglutination, Radioimmunoassay (RIA), Immunoperoxidase Staining, Immunofluorescence, and Others], and End User [Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, and Research Institutes] ,” the market was valued at US$101.41 million in 2019 and is projected to reach US$236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020–2027. The report highlights the trends prevailing in the global viral antigens market, and drivers and restraints pertaining to its growth. The growth of the market is mainly attributed to the increasing prevalence of viral diseases, escalated acceptance for viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, emerging markets present significant opportunities for the players operating in the global viral antigens market.

Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00017334/?utm_source=article&utm_medium=10682

Most of the recently established techniques, such as electron microscopy, are promising sand trigger advancements in viral research. For example, advancements in imaging systems have enabled effective and reproducible real-time image capture and immunoassay results can be obtained. In vaccine research and development, regular outbreaks of virus-induced infectious diseases, such as influenza, hepatitis, AIDS, and, more recently, COVID-19 are causing urgency. This, in turn, is expected to lead to rapid growth in the demand for viral antigens.

Image analysis software can be used to extract useful knowledge to gain new insights, and accelerate decision-making, as well as make it more assured. Effective image analysis software makes it far easier for researchers to produce and analyze image data from cellular samples and in vivo models. From 2D and 3D optical imaging to advanced microCT analysis and co-registration of data from other modalities, in vivo imaging software help capture the same, easy-to-use, scalable, high-performance, quantitative software solutions that are crucial to get significant outcomes from in vivo research. Similarly, cellular imaging and analysis tools can help collect, visualize, interpret, and exchange image information more easily and efficiently, which helps make vaccine discovery process less time-consuming.

Key Market Players:

Microbix Biosystems, BIO-RAD Laboratories INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-TanyTechnogene Ltd., ACROBiosystems., Meridian Bioscience, Inc., Rekom Biotech S.L, and LGC Limited are among the players operating in the viral antigens market. These players focus on product developments and innovation to sustain their market positions. For instance, in October 2020, Microbix Biosystems Inc. entered into an agreement with the Ontario Together Fund of the Ministry of Economic Development, Job Creation and Trade. The company received OTF grant of US$ 1.45 million to cover 50% of the cost to automate the production of Microbix’s quality assessment products that help assure the accuracy of the disease diagnostic testing, and enable local, secure, and cost-effective automated production of viral transport media required for Ontario’s nucleic acid testing projects related to COVID-19.

The report segments the global viral antigens market as follows:

By Component

1.  Influenza Viral Antigens

By Technique

ELISA

Immunoassay

Hemagglutination

Radioimmunoassay (RIA)

Immunoperoxidase Staining

Immunofluorescence

Others

BIO-RAD Laboratories Inc., Meridian Bioscience, Inc. – Notable Participants in Viral Antigens Market

A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.

A few of the most notable companies occupying a considerable share of the market are Microbix Biosystems, BIO-RAD Laboratories INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-Tany Technogene Ltd., ACROBiosystems., Meridian Bioscience, INC., Rekom Biotech S.L, and LGC Limited.

Market leaders are involved in partnerships, product launches, acquisitions, and other strategies to improve their performance and consolidate the market position. For instance,  In July LGC Group acquired The Native Antigen Company, one of the world’s leading suppliers of high-quality infectious disease antigens and antibodies, based in Oxford, UK, for consideration of £15.7m. The net assets of the acquired business were £4.8m.

Prominent players in the viral antigens market are focusing on organic strategies such as product launches, product approvals, and geographic and manufacturing expansions. These strategies help them strengthen their market positions, along with allowing them to broaden their geographic footprints.

]About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Laser weapon systems market key factors driving the market growth and prominent players with their developments in the market.

According to our latest market study on “Laser Weapon Systems Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Type (Chemical Laser, Solid-State Laser, Free Electron Laser, and Fiber Laser) and Application (Air-based, Ground-based, and Sea-based),” the market was valued at US$ 1,342.17 million in 2020 and is projected to reach US$ 5,123.18 million by 2028; it is expected to grow at a CAGR of 18.8% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.

The global laser weapon systems market has been analyzed based on historical, current, and future trends in the countries across the world. Laser weapon systems provide highest strength to defense against aerial attacks. Thus, it has major adoption in military weapon systems. Increasing investments in the military and defense sector in developed as well as developing nations are propelling the growth of the laser weapon systems market. Also, there is an immense growth in the laser weapon technology. Hence, in coming years, each country is expected to witness the launch of more enhanced laser weapon systems offering high quality precision and power for high-energy.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00018346/ ?utm_source=article&utm_medium=10682

 As developing nations are identifying the potential of laser weapon systems, the players operating in the laser weapon systems market are focused to form weapon development agreements with these nations. The COVID-19 outbreak caused various disruptions in the market such as slowdown in production and delays in projects of some countries due to unstable economy. Besides, the growing demand for high-energy laser weapon system from developing countries such as India and China is compelling the laser weapon systems manufacturers to improve offerings a per the needs. Companies operating in the market adopt various marketing strategies, such as new product developments, partnerships, and acquisitions, to optimize their existing offerings and expand their portfolio to target a significant number of customers.

For instance, in March 2021, SIGN4L, a UAE-based company offering electronic warfare and intelligence solution, signed a memorandum of understanding (MoU) with Cilas and MBDA to explore the field of high-energy laser weapons systems. Under this MoU, the three entities are developing advanced high-energy laser weapons systems for counter-unmanned aerial vehicle (C-UAV) strategy. Thus, all these factors are driving the growth of the global laser weapon systems market.

Surge in Demand from Emerging Countries to Provide Numerous Business Opportunities for Market Players

The aircraft sector in North America, Europe, and Asia pacific is growing at the fastest rate with an advent of supporting high-energy and more precise technologies. China, India, and Russia are among the countries that are strongly adopting the laser weapon systems. Further, rising strain among Asian countries is strongly supporting the growth of the laser weapon systems market. For instance, both India and China are upgrading existing weapons and purchasing new ones from European countries amid rising issue at Galvan Valley for the line of control positioning. Other Asian countries are also strengthening their military weapons. For instance, South Korea is upgrading its aircrafts and ground armory near borders of China and Russia, as invasion of aircrafts in non-flying zone from the both countries is increased. 

The report segments the global laser weapon systems market as follows:

By Type

Chemical Laser

Solid-State Laser

Free Electron Laser

Fiber Laser

By Application

Air-based

Ground-based

Sea-based

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876

[ankushmakde]

Hospital mobile X-ray market was valued at US$ 1,604.92 million in 2019 and it is projected to reach US$ 3,479.79 million by 2027

According to the latest study on “Hospital Mobile X-Ray Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Technology, Configuration, and Ward,” the market was valued at US$ 1,604.92 million in 2019 and it is projected to reach US$ 3,479.79 million by 2027; it is expected to grow at a CAGR of 10.2% during 2020–2027. The report highlights trends prevailing in the global market, and drivers and restraints pertaining to the market growth.

Increasing awareness about early diagnosis and rising prevalence of chronic conditions, and better patient experience are fueling the growth of the global hospital mobile X-Ray market. Further, rising number of hospitals and diagnostics centers offers lucrative opportunities to the market players. However, the poor reimbursement for diagnostic equipment hinders the market growth.

Request for Sample Report @ https://www.theinsightpartners.com/sample/TIPRE00018329/ ?utm_source=article&utm_medium=10682

Hospital mobile X-ray market Segmentation:

Based on thechnology, the hospital mobile X-ray market is segmented into computed radiography, and direct radiography. In 2019, the computed radiography segment accounted for the largest share of the market.

Agfa-Gevaert Group, SEDECAL, IDETEC MEDICAL IMAGING, Koninklijke Philips N.V., SternMed GmbH, DMS Imaging, Carestream Health Inc., INTERMEDICAL S.r.l. IMD Group, DELFT IMAGING, and OR Technology are among the key players operating in the hospital mobile X-ray market. These companies focus on partnerships, product launches, and collaborations to sustain their positions in the market. For instance, in April 2020, Carestream Health Inc. increased its production of mobile imaging systems during the COVID-19 pandemic to meet the increasing demand for mobile X-ray systems.

The report segments the global hospital mobile X-ray market as follows:

By Technology

Computed Radiography

Direct Radiography

By Configuration

Fixed Arm

Rotating Arm

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1–646–491–9876